CLV strong H1 results & product pipeline

Pure Cycle and Clover Corporation reported strong first-half results, driving optimism in their respective sectors.

Pure Cycle, a real estate development company, reported $5.1M in revenue, $2.8M in gross profit, and $1.0M in net income through H1, up 36% year-over-year. The company reiterated full-year revenue guidance of $26-30M and EPS of $0.43-0.52, with potential upside tied to lot deliveries. Clover Corporation, a nutritional solutions provider, also reported strong H1 results, driven by its technology-driven approach to delivering omega-3 and omega-6 nutritional solutions, supporting global growth.

These results have positively impacted the real estate and nutritional supplements sectors. Pure Cycle's strong performance has boosted investor confidence in the housing market, while Clover Corporation's growth has driven interest in the health and wellness sector, particularly in nutritional supplements.

Investors should watch for Pure Cycle's Q3 earnings report, scheduled for August 2023, and Clover Corporation's full-year results, expected in late 2023. Additionally, Clover Health Investments' strategic partnership with HealthEX, announced in April 2023, could drive further growth and should be closely monitored.